Paper35455686
The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis.
Wolfe HR and 2 others. J Pers Med, 2022. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis. Papers, record 35455686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35455686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26970380 | Outcome after Transplantation According to Reduced-Intensity Conditioning Regimen in Patients Undergoing Transplantation for Myelofibrosis. | Biol Blood Marrow Transplant | 2016 | https://conductscience.org/library/papers/26970380 | PubMed |
| 2 | 17151367 | The myeloproliferative disorders. | N Engl J Med | 2006 | https://conductscience.org/library/papers/17151367 | PubMed |
| 3 | 22375971 | A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22375971 | PubMed |
| 4 | 12920019 | Allogeneic hematopoietic stem cell transplantation for myelofibrosis. | Blood | 2003 | https://conductscience.org/library/papers/12920019 | PubMed |
| 5 | 24986690 | Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. | Blood | 2014 | https://conductscience.org/library/papers/24986690 | PubMed |
| 6 | 10331505 | Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. | Am J Hematol | 1999 | https://conductscience.org/library/papers/10331505 | PubMed |
| 7 | 28561069 | A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis. | Leukemia | 2017 | https://conductscience.org/library/papers/28561069 | PubMed |
| 8 | 24292520 | Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib. | Bone Marrow Transplant | 2014 | https://conductscience.org/library/papers/24292520 | PubMed |
| 9 | 26916563 | Impact of ruxolitinib treatment on the hemoglobin dynamics and the negative prognosis of anemia in patients with myelofibrosis. | Leuk Lymphoma | 2016 | https://conductscience.org/library/papers/26916563 | PubMed |
| 10 | 24389309 | Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. | Haematologica | 2014 | https://conductscience.org/library/papers/24389309 | PubMed |
| 11 | 8426474 | Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. | Leukemia | 1993 | https://conductscience.org/library/papers/8426474 | PubMed |
| 12 | 26181658 | Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial. | JAMA Oncol | 2015 | https://conductscience.org/library/papers/26181658 | PubMed |
| 13 | 16834459 | MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. | PLoS Med | 2006 | https://conductscience.org/library/papers/16834459 | PubMed |
| 14 | 30408564 | Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30408564 | PubMed |
| 15 | 29791053 | Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis. | Eur J Haematol | 2018 | https://conductscience.org/library/papers/29791053 | PubMed |
| 16 | 29800615 | Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation. | Biol Blood Marrow Transplant | 2018 | https://conductscience.org/library/papers/29800615 | PubMed |
| 17 | 19879949 | Outcome of transplantation for myelofibrosis. | Biol Blood Marrow Transplant | 2010 | https://conductscience.org/library/papers/19879949 | PubMed |
| 18 | 20425397 | Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in myelofibrosis. | Curr Hematol Malig Rep | 2010 | https://conductscience.org/library/papers/20425397 | PubMed |
| 19 | 22212965 | One thousand patients with primary myelofibrosis: the mayo clinic experience. | Mayo Clin Proc | 2012 | https://conductscience.org/library/papers/22212965 | PubMed |
| 20 | 20439618 | Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis. | Blood | 2010 | https://conductscience.org/library/papers/20439618 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| ASXL1 | 171023 | PubTator's text mining | https://conductscience.org/library/genes/171023 | NCBI Gene |
| BCR | 613 | PubTator's text mining | https://conductscience.org/library/genes/613 | NCBI Gene |
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| EZH2 | 2146 | PubTator's text mining | https://conductscience.org/library/genes/2146 | NCBI Gene |
| IDH1 | 3417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
| IDH2 | 3418 | PubTator's text mining | https://conductscience.org/library/genes/3418 | NCBI Gene |
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
| MPL | 4352 | PubTator's text mining | https://conductscience.org/library/genes/4352 | NCBI Gene |
| SRSF2 | 6427 | PubTator's text mining | https://conductscience.org/library/genes/6427 | NCBI Gene |
| U2AF1 | 7307 | PubTator's text mining | https://conductscience.org/library/genes/7307 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35455686
GET https://conductscience.org/api/papers/v1/35455686/references?page=2